Search

everythinglearnresearchcommunity

for

Search:↓

The symposium showed that stem cells are key for understanding and treating skin diseases and for developing new skin models and therapies.

A new mutation in the CYP11B1 gene was found in a woman with mild hyperandrogenemia, a rare cause of non-classic congenital adrenal hyperplasia.

Premature greying of hair affects the social lives of medical students but not their self-esteem.

A genetic test can identify people at risk of male pattern baldness early, allowing for quicker treatment.

Most YouTube hair loss treatment videos are popular but often biased and lack reliable sources.

Trichoscopy is useful for assessing androgenetic alopecia severity but can't determine hair loss stage alone.

A new tool helps study hair follicle cells to develop better treatments for hair disorders.

The multimedia tool improved patient understanding of PRP treatment for hair loss.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

Ginkgo biloba has high genetic diversity, useful for future breeding.

Individualized Homeopathic Medicine shows promise for treating alopecia with lasting hair regrowth.

AI can effectively detect hair and scalp disorders from images.

Organoids help study and treat genetic diseases, offering personalized medicine and therapy testing.

Multiple treatments work best for hair loss.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

This therapy effectively treats resistant alopecia areata with minimal side effects.

Dupilumab helped a woman with severe hair loss regrow her hair quickly and maintain it for six months after stopping treatment.

Intralesional corticosteroids are the best for limited alopecia areata, oral steroids are less effective, and PRP is safe and promising, especially for children and severe cases.

Pix Liquida may help treat alopecia areata.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

The combination of calcipotriol and PRP is the most effective treatment for alopecia areata.

Ruxolitinib helped a woman with a genetic mutation regrow her hair and improved her health.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

Hydroxychloroquine is less effective than betamethasone oral mini pulse therapy for treating alopecia areata.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.

Measuring reproductive hormones in brown bear hair could help identify their sex and reproductive state, but better collection methods or lab techniques are needed.

Tofacitinib may help treat severe hair loss, but more research is needed.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.